Company Overview
Denali Therapeutics is committed to conquering neurodegenerative diseases by overcoming research and development obstacles to provide effective and safe medicines. Our approach centers on strong genetic target validation, innovative brain delivery methods, and biomarker-guided development. We foster a scientifically driven, collaborative, and supportive environment where diverse expertise unites to defeat degeneration and positively impact lives.